Vaccines for Children (VFC) FY26
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
000HCJBC-2025-95504
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Centers for Disease Control and Prevention (CDC), through its Office of Acquisition Services, has issued a Combined Synopsis/Solicitation for the procurement of pediatric vaccines under the Vaccines for Children (VFC) program for Fiscal Year 2026. This initiative, identified by Procurement Identifier 000HCJBC-2025-95504, seeks to establish contracts with qualified manufacturers for the supply of standard commercial pediatric vaccines. The place of performance for this contract is Atlanta, Georgia.
The VFC program, established under Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93), is a cornerstone of the nation’s immunization strategy. Its primary purpose is to ensure a reliable and sufficient supply of vaccines for children who meet specific eligibility criteria, thereby supporting effective immunization practices and increasing coverage rates among vulnerable populations. The program targets children 18 years of age or younger who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or underinsured (provided they receive immunizations at Federally-qualified health centers or rural health clinics).
Through this procurement, the CDC aims to leverage federal funds, including VFC and Section 317 vaccine purchase funds, to acquire vaccines at prices below those available in the commercial marketplace. This approach not only maximizes the reach of federal resources but also allows awardees the option to purchase additional vaccine quantities using state and local funds for children who do not qualify for federal vaccine support.
Key requirements for this opportunity stipulate that offerors must be manufacturers of pediatric vaccines as defined by 42 U.S.C. §1396s. The definition of "manufacturer" encompasses any corporation, organization, or institution—public or private, including federal, state, and local entities—that manufactures, imports, processes, or distributes pediatric vaccines under its own label. Only entities meeting this definition are eligible to respond.
The scope of the contract includes the supply of standard commercial pediatric vaccines, with the expectation that awardees will ensure timely and sufficient delivery to meet the needs of eligible children nationwide. The CDC anticipates that these contracts will support both federally and non-federally eligible children, depending on the funding source utilized by the purchasing entity.
This procurement is classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505. There are no set-aside restrictions associated with this solicitation, making it open to all qualified manufacturers regardless of business size or socioeconomic status.
Interested parties should note that the CDC Office of Acquisition Services is the contracting entity for this opportunity. The primary point of contact is James Sprigler ([email protected]), with Chad Turner ([email protected]) serving as the secondary contact. The solicitation was posted on December 19, 2025, with responses due by January 14, 2026. Additional details, including attachments, can be accessed via the official SAM.gov opportunity listing (Opportunity ID: 5d66384610f64777ae0f5e3aa315ec30).
This procurement represents a significant opportunity for pediatric vaccine manufacturers to contribute to a critical public health initiative, ensuring that vulnerable children across the United States have access to life-saving immunizations. Contractors considering this opportunity should carefully review the eligibility requirements and be prepared to demonstrate their capacity to manufacture, supply, and distribute pediatric vaccines in accordance with federal standards and program objectives.
Documents8